With expression in various malignant cells, such as endometrial, ovarian, and triple-negative breast cancer (TNBC) cells, LHRH has been recognized for its role in the negative autocrine/paracrine regulatory mechanism of cell proliferation [20,21,22]. Here, GNRH1 is linked to triple-negative breast carcinoma.